• Johnson & Johnson (JNJ) has begun late-stage trial of its COVID-19 vaccine candidate - CNBC

Notícias do Mercado

23 setembro 2020

Johnson & Johnson (JNJ) has begun late-stage trial of its COVID-19 vaccine candidate - CNBC

Johnson & Johnson is the fourth drugmaker backed by the Trump administration’s Covid-19 vaccine program Operation Warp Speed to enter late-stage testing, CNBC noted. The other companies are Moderna (MRNA), Pfizer (PFE) and AstraZeneca (AZN).

O foco de mercado
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer
Abrir Conta Demo e Página Pessoal
Compreendo e aceito a Política de Privacidade e concordo que os meus dados sejam processados pela TeleTrade e usados para os seguintes efeitos: